A. Tylkiszymanska et al., PRACTICAL SUGGESTIONS IN DIAGNOSING METACHROMATIC LEUKODYSTROPHY IN PROBANDS AND IN TESTING FAMILY MEMBERS, European neurology, 40(2), 1998, pp. 67-70
Metachromatic leukodystrophy (MLD) is one of the most severe genetical
ly determined demyelination diseases. It is caused by a deficit in the
activity of sulfatide sulfatase. The diagnosis is made by demonstrati
ng a deficiency of arylsulfatase A (ASA) activity in leukocytes or cul
tured skin fibroblasts. Diagnosis based only on the activity of ASA is
complicated by the fact that there exists a condition of ASA pseudode
ficiency (Pd). Due to the relatively high risk of the MLD/Pd and MLDPd
/Pd genotypes among families of patients, it is possible to make an er
roneous diagnosis on the basis of only ASA activity. Nonetheless, it s
eems necessary to develop a reliable and simple diagnostic procedure s
o as to enable diagnosis and genetic counseling for carriers. We prese
nt two diagnostic flow charts entailing determination of ASA activity,
identification of the pseudodeficit mutation and detection of sulfati
des in a 24-hour urine collection.